The deal priced below last closing price of $23.40. JPMorgan, TD Cowen, SVB Securities and Guggenheim are acting as joint book running managers for the offering.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on RVMD:
- Revolution Medicines Announces Pricing of $300.0 Million Public Offering of Common Stock
- Revolution Medicines announces $300M common stock offering
- Revolution Medicines Announces Commencement of Public Offering of Common Stock
- Revolution Medicines Blasts Up after Earnings
- Revolution Medicines price target raised to $38 from $32 at Needham